PharmaMar announces data presentations: Yondelis ® and lurbinectedin at ASCO

(Pharmamar) During the Congress of the American Society of Clinical Oncology (ASCO) that will be held form the June 1-5 in Chicago (USA), PharmaMar will present the data obtained from various clinical studies of the molecules Yondelis ® , lurbinectedin (PM1183) and plitidepsin.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news